Differences in metabolic profiles between bicuspid and tricuspid aortic stenosis in the setting of transcatheter aortic valve replacement
Authors:
Open Access
- 18 May 2020
- journal article
- research article
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 20 (1) , 1-10
Abstract
Background: To explore why bicuspid aortic stenosis has certain clinical differences from the tricuspid morphology, we evaluated the metabolomics profile involved in bicuspid aortic valve (BAV) aortic stenosis prior to and after transcatheter aortic valve replacement (TAVR) in comparison with tricuspid aortic valve (TAV). Methods: In this TAVR cohort with prospectively collected data, blood samples were obtained before TAVR valve deployment and at the 7th day after TAVR, which were then sent for liquid and gas chromatography-mass spectrometry detection. Besides comparisons between BAV and TAV, BAV patients were also divided in subgroups according to baseline hemodynamics (i.e. maximal transaortic velocity, Vmax) and post-procedural reverse left ventricular (LV) remodeling (i.e. the change in LV mass index from baseline, ∆LVMI) for further analysis. Metabolic differences between groups were identified by integrating univariate test, multivariate analysis and weighted correlation network analysis algorithm. Results: A total of 57 patients were enrolled including 33 BAV patients. The BAV group showed lower arginine and proline metabolism both before and post TAVR than TAV represented by decreased expression of L-Glutamine. In BAV subgroup analysis, patients with baseline Vmax > 5 m/s (n = 11) or the 4th quartile of change in ∆LVMI at one-year follow-up (i.e. poorly-recovered LV, n = 8) showed elevated arachidonic acid metabolism compared with Vmax < 4.5 m/s (n = 12) or the 1st quartile of ∆LVMI (i.e. well-recovered LV, n = 8) respectively. Conclusions: Difference in arginine and proline metabolism was identified between BAV and TAV in TAVR recipients. Elevated arachidonic acid metabolism may reflect more severe baseline hemodynamics and worse LV reserve remodeling after TAVR in BAV.Keywords
Funding Information
- National Natural Science Foundation of China (81970325)
- Science and Technology Support Plan of Sichuan province (2018SZ0172)
- West China Hospital, Sichuan University (“1·3·5” Discipline of Excellence Project)
This publication has 34 references indexed in Scilit:
- Perturbations in fatty acid metabolism and apoptosis are manifested in calcific coronary artery disease: An exploratory lipidomic studyInternational Journal of Cardiology, 2015
- COX2 Inhibition Reduces Aortic Valve Calcification In VivoArteriosclerosis, Thrombosis, and Vascular Biology, 2015
- Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular ImagingJournal of the American Society of Echocardiography, 2015
- DanQi Pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes B4BMC Complementary and Alternative Medicine, 2014
- Proline Mechanisms of Stress SurvivalAntioxidants & Redox Signaling, 2013
- Disruption of group IVA cytosolic phospholipase A2attenuates myocardial ischemia-reperfusion injury partly through inhibition of TNF-α-mediated pathwayAmerican Journal of Physiology-Heart and Circulatory Physiology, 2012
- Nitric oxide signaling and the regulation of myocardial functionJournal of Molecular and Cellular Cardiology, 2008
- Natural History of Asymptomatic Patients With Normally Functioning or Minimally Dysfunctional Bicuspid Aortic Valve in the CommunityCirculation, 2008
- Endothelial Nitric Oxide Synthase in Bicuspid Aortic Valve DiseaseThe Annals of Thoracic Surgery, 2007
- Metabolomics or metabolite profiles?Trends in Biotechnology, 2005